These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Relationship between B-type natriuretic peptide and short-term prognosis in non-diabetic patients with ST-segment elevation myocardial infarction. Wei P; Fu Q; Tao ZQ; Han B; Zhang YG; Huang YJ; Ling L; Yang XJ Eur Rev Med Pharmacol Sci; 2016; 20(4):721-5. PubMed ID: 26957276 [TBL] [Abstract][Full Text] [Related]
10. Value of brain natriuretic peptide after acute myocardial infarction. Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723 [TBL] [Abstract][Full Text] [Related]
11. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. Tsutamoto T; Wada A; Sakai H; Ishikawa C; Tanaka T; Hayashi M; Fujii M; Yamamoto T; Dohke T; Ohnishi M; Takashima H; Kinoshita M; Horie M J Am Coll Cardiol; 2006 Feb; 47(3):582-6. PubMed ID: 16458140 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction. Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035 [TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of intensive statin therapy on N-terminal pro-BNP level in non-ST-segment elevation acute myocardial infarction patients. Shehata M; Samir A; Dardiri M J Interv Cardiol; 2017 Dec; 30(6):514-521. PubMed ID: 28812321 [TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group. Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344 [TBL] [Abstract][Full Text] [Related]
15. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort. Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733 [TBL] [Abstract][Full Text] [Related]
16. TRPV6 Is Associated with Prognosis of ST-Elevation Acute Myocardial Infarction. Zhang H; Ding P; Zheng L Ann Clin Lab Sci; 2020 Nov; 50(6):775-780. PubMed ID: 33334793 [TBL] [Abstract][Full Text] [Related]
17. Does estimated glomerular filtration rate have an effect on left ventricular function after ST-elevation myocardial infarction? Sonmez O; Vatankulu MA; Tasal A; Bacaksiz A; Ayhan S; Yazici HU; Karakaya E; Ozdogru I; Aygul N; Ozdemir K; Abaci A Echocardiography; 2014 Mar; 31(3):318-24. PubMed ID: 24103085 [TBL] [Abstract][Full Text] [Related]
18. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy. Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832 [TBL] [Abstract][Full Text] [Related]
19. Reduced Cardio-Renal Function Accounts for Most of the In-Hospital Morbidity and Mortality Risk Among Patients With Type 2 Diabetes Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Marenzi G; Cosentino N; Genovese S; Campodonico J; De Metrio M; Rondinelli M; Cornara S; Somaschini A; Camporotondo R; Demarchi A; Milazzo V; Moltrasio M; Rubino M; Marana I; Grazi M; Lauri G; Bonomi A; Veglia F; De Ferrari GM; Bartorelli AL Diabetes Care; 2019 Jul; 42(7):1305-1311. PubMed ID: 31048409 [TBL] [Abstract][Full Text] [Related]